← Leaderboards
Catherine M Bender
University Of Pittsburgh At Pittsburgh
$7,529,289
Attributed
$10,518,865
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$10,518,865 · 6
By mechanism
R01$9,015,258 · 3
T32$1,348,323 · 1
P30$155,284 · 2
Top collaborators
- Kirk I Erickson10 shared
- Yvette P Conley5 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Kirk I Erickson$29,375,219
- Georgios Kitsios$1,686,471
- Vanessa Brown$1,636,151
- Stephen Y Lai$10,561,066
- Yehui Zhu$486,790
Others in their field
Top investigators on “Symptoms”
- Randall J Bateman · Washington University$155,860,406
- Judith S Hochman · New York University School Of Medicine$111,581,511
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$98,224,091
- Eric Martin McDade · Washington University$96,219,353
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Monica M Bertagnolli · Strang Cancer Prevention Center$85,994,687
Research focus
SymptomsCognitive FunctionAromatase InhibitorsWomanMediatingImpaired CognitionPostmenopauseCognitiveAnxietyMental DepressionMalignant Breast NeoplasmBiologicalSleep DisordersAttentionRandomizedPathway InteractionsMalignant NeoplasmsFatigueBrainSamplingHormone TherapyMemoryAdjuvant TherapyGray Matter
Grant awards (29)
Biobehavioral Cancer Control Program$40,109
P30 · FY2023 · CA · contact PI
Epigenomics of Neurocognitive Function in Breast Cancer$401,691
R01 · FY2022 · CA
Biobehavioral Cancer Control Program$40,109
P30 · FY2022 · CA · contact PI
Epigenomics of Neurocognitive Function in Breast Cancer$401,031
R01 · FY2021 · CA
Biobehavioral Cancer Control Program$35,587
P30 · FY2021 · CA · contact PI
Influence of Exercise on Neurocognitive Function in Breast Cancer$619,121
R01 · FY2020 · CA · contact PI
Epigenomics of Neurocognitive Function in Breast Cancer$534,005
R01 · FY2020 · CA
Biobehavioral Cancer Control Program$39,479
P30 · FY2020 · CA · contact PI
Influence of Exercise on Neurocognitive Function in Breast Cancer$574,295
R01 · FY2019 · CA · contact PI
Epigenomics of Neurocognitive Function in Breast Cancer$428,428
R01 · FY2019 · CA
Influence of Exercise on Neurocognitive Function in Breast Cancer$607,082
R01 · FY2018 · CA · contact PI
Epigenomics of Neurocognitive Function in Breast Cancer$448,884
R01 · FY2018 · CA
Influence of Exercise on Neurocognitive Function in Breast Cancer$617,516
R01 · FY2017 · CA · contact PI
Influence of Exercise on Neurocognitive Function in Breast Cancer$609,087
R01 · FY2016 · CA · contact PI
Long Term Trajectory of Cognitive Function Related to Anastrozole Use in Women$365,785
R01 · FY2015 · CA · contact PI
Long Term Trajectory of Cognitive Function Related to Anastrozole Use in Women$367,422
R01 · FY2014 · CA · contact PI
Interdisciplinary Training of Nurse Scientists in Cancer Survivorship Research$106,047
T32 · FY2014 · NR · contact PI
Interdisciplinary Training of Nurse Scientists in Cancer Survivorship Research$388,391
T32 · FY2013 · NR · contact PI
Long Term Trajectory of Cognitive Function Related to Anastrozole Use in Women$361,345
R01 · FY2013 · CA · contact PI
Interdisciplinary Training of Nurse Scientists in Cancer Survivorship Research$418,518
T32 · FY2012 · NR · contact PI
Long Term Trajectory of Cognitive Function Related to Anastrozole Use in Women$383,368
R01 · FY2012 · CA · contact PI
Long Term Trajectory of Cognitive Function Related to Anastrozole Use in Women$392,037
R01 · FY2011 · CA · contact PI
Interdisciplinary Training of Nurse Scientists in Cancer Survivorship Research$327,614
T32 · FY2011 · NR · contact PI
Interdisciplinary Training of Nurse Scientists in Cancer Survivorship Research$107,753
T32 · FY2010 · NR · contact PI
Cognitive Impairment Related to Anastrozole Use in Women$380,322
R01 · FY2009 · CA · contact PI
Cognitive Impairment Related to Anastrozole Use in Women$374,641
R01 · FY2008 · CA · contact PI
Cognitive Impairment Related to Anastrozole Use in Women$365,898
R01 · FY2007 · CA · contact PI
Cognitive Impairment Related to Anastrozole Use in Women$369,665
R01 · FY2006 · CA · contact PI
Cognitive Impairment Related to Anastrozole Use in Women$413,635
R01 · FY2005 · CA